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Tissue Engineering
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Abstract
Meniscus plays fundamental roles in the knee mechanisms and functions. 
It acts as a shock absorber where it enables even distribution of forces, and also 
lubricates knee joints. Meniscal injuries could result to the onset of degenerative 
osteoarthritis if proper treatments are delayed. To date, treatment of meniscal 
injuries are more towards conservative methods and surgical approach commonly 
known as meniscectomy. Attempts to develop scaffolds for meniscus implants 
from synthetic and biological sources have been done in the recent years. This 
approach involves a multidisciplinary study known as tissue engineering and 
regenerative medicine. It involves the combination of three crucial aspects; the 
choice of chondrogenic/stem cells, bioscaffolds and favourable environmental fac-
tors such as growth factors. This chapter discusses and highlights on the currently 
available meniscal scaffolds that have been explored before. Focus is also directed 
on the potential of decellularized extracellular matrix (ECM), prepared through 
sonication treatment that produced scaffolds which mimics natural meniscus. 
The evaluation of decellularized scaffolds was portrayed through recellularization 
using cells namely chondrocytes, fibrochondrocytes and stem cells in order to 
regenerate new functional tissue. In short, this chapter serves as a representation 
of current approaches aiming in bio-engineering the meniscal scaffolds as menis-
cus tissue replacement.
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1. Introduction
Tissue engineering is deemed as a promising therapeutic tool in treating disease 
and injuries. There are three crucial aspects in determining the success of this 
approach which is by combining cells, biomaterial scaffolds and biologically active 
molecules such as growth factors. Developing three-dimensional scaffolds or 
constructs that could serve similarly as native tissue is utterly important. A scaffold 
should provide support and space for cells to grow, migrate and adhere and continu-
ally retain their phenotype. Hence, scaffolds should be biocompatible and biode-
gradable in the sense that it is able to propagate appropriate signals for the seeded 
cells execute normal cell homeostasis and processes.
Specifically, numerous growth factors have been used on meniscal fibro-
chondrocytes to evaluate their potential in healing tears or on protein synthesis 
using cell culture conditions. The most utilized is transforming growth factor-b 
(TGF-b). Studies by Marx et al. and Dunsmore et al. showed that TGF-b increases 
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the proteoglycan synthesis of fibrochondrocytes from all different sections of the 
meniscus. Besides, hepatocyte growth factor (HGF) or bone-morphogenic pro-
tein-2 (BMP-2) was also shown to increase DNA synthesis. To add, cell migration 
rate improved with the usage of HGF and BMP-2 [1, 2] Other growth factor such 
as interleukin-1 (IL-1) was also reported to stimulate migration of cells taken from 
the peripheral third of the tissue. The famous fibroblastic growth factor (FGF) was 
studies by Webber et al. to show proliferation and stimulate the growth of fibro-
chondrocytes and human platelet lysate (PL) [3].
Next, the key aspect in the success of tissue engineering is the development of 
effective scaffolds which can serve to replace injured or damaged tissue. Thus for 
a successful meniscus replacement, consideration in the optimal scaffolds proper-
ties such as biomechanical, immunogenicity and potential to recellularize cells are 
important to be scrutinized. The highlight of this chapter would be discoursing 
different options in developing novel scaffolds of meniscal tissue replacement. The 
meniscus primarily functions as a load bearer and shock absorber. Degenerative 
or traumatic loss of meniscal tissue sometimes requires multiple surgical proce-
dures to be treated. Ideally, treatment of meniscal injury should be focusing on 
the preservation and restoration of the meniscus function. However, effort of 
complete replacement of meniscus is deemed warranted in more severe cases. 
Various types of transplant have been done at the experimental and clinical level 
for example allogenic and autologous meniscus transplant. Issues such as host reac-
tions towards major histocompatibility complexes of the donor, lead to progressive 
decellularization and consecutive failure of the transplant in meniscus allograft 
transplantation. To date, none of the proposed replacement methods could provide 
long-term chondroprotective effect. Scaffolds are necessary for tissue engineered 
meniscus replacement and considerations such as biomechanical, cell toxicity 
and immunological response of the host towards the scaffolds are crucial to be 
scrutinized. There is evidence suggesting that degenerative tears in older patients 
without mechanical symptoms can be effectively treated non-operatively with a 
structured physical therapy programme as a first line. Even if these patients later 
require meniscectomy they will still achieve similar functional outcomes than if 
they had initially been treated surgically. While, partial meniscectomy is more 
suitable for symptomatic tears which is hard to repair but could still preserve 
meniscal function.
2. Composition and cell characteristics of meniscus
Meniscus possesses a highly heterogeneous extracellular matrix (ECM) and 
has a wide range of cell distribution [4]. The ECM of meniscus is categorized by 
region. Collagen type I accounts for >80% of the composition in the red-red region 
by dry weight, and the remaining content comprises <1%, including collagen types 
II, III, IV, VI, and XVIII [5]. There is about 70% of collagen from the dry weight in 
the white-white region. On the other hand, collagen types II and I account for 60 
and 40%, respectively. Next, the cell population in meniscus is categorized into 4 
types based on where it resides. First, the outer one-third of the meniscal area is 
comprised of fibroblast-like cells, demonstrated by elongated shapes while outer 
periphery contain many cell processes like fibroblasts. Second, the inner two-thirds 
of the meniscal region mainly contain fibrochondrocytes, oval to round in shape. 
The inner avascular region comprised more rounded and chondrocyte-like cells. 
Lastly, fusiform cells are positioned parallel to the meniscal surface at the superfi-
cial zone [6].
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3. Currently available scaffolds for meniscus
Meniscus scaffolds serves as a platform for the ingrowth of cells and provide 
support for the remodeling of the native tissue. There are two categories of scaf-
folds available; synthetic and biological types. There is a wide variety of synthetic 
scaffolds that have been explored. Polymer based scaffolds have been tested in a 
few experimental animal studies. Fibrocartilage-like tissue was able to grow in 
about 3 months’ time after the seeding/implantation [7]. They also reported that 
in control group, degeneration of hyaline cartilage proceeded slower but could not 
be halted. To add, other bioabsorbable synthetic polymers, such as polyurethane 
(PU), polyglycolic acid (PGA), polylactic acid, and poly (𝜀- caprolactone) (PCL) 
are also widely studies to play important part in supporting the development 
of meniscal scaffolds [8, 9]. The main advantages of using polymer as the main 
material in scaffolds development is that they provide versatility, comparable 
biomechanical properties with native tissues and easily available material supply. 
However, there are some downside of using synthetic polymers which include 
their hydrophobic properties, non-biocompatibility issues, immunorejection and 
inflammation. Thus, many attempts have been done to improve polymer based 
scaffolds. One of them is Koller et al. whom had attempt to enhance the bioactivity 
of synthetic scaffolds by adding polyethylene terephthalate (PET) to hyaluronic 
acid/PCL scaffolds and the results were positive [10]. Scaffolds with PET were 
recorded to express more type II collagen mRNA and secreted more GAGs than 
without PET. Besides that, Baker and Mauck developed aligned (AL) scaffolds by 
electrospinning whereby cells in the AL group showed AL morphology whereas 
those in the control group took a polygonal shape [11]. Koller et al. improved 
PGA by reinforcing bonding with PLGA at a ratio of 75:25 in order to fabricate 
meniscus-like scaffolds [10]. Allogenic meniscal cells were seeded into the scaffolds 
in vitro for 1 week to replace the medial meniscus in rabbits. The results showed 
neomenisci are able to be regenerated which is similar to the native meniscus. 
However, the newly form neomenisci were not capable to prevent articular carti-
lage from further degenerating.
They are two main types of natural scaffolds which are tissue derived materi-
als, extra cellular matrix (ECM) components and decellularized tissue. Some of 
the tissue derived materials that have been studied comprised of small intestine 
submucosa (SIS), periosteal tissue, and perichondral tissue. Cook et al. have done 
studies of SIS in dogs and showed promising results. However the study only 
lasted for 12 week and no mechanical testing was done [12]. One of the significant 
tests is their major animal trial which consisted of removing 80% of the medial 
meniscus of the dog and replacing it with this scaffold. The results after 3 years 
of implantation were promising which showed no degeneration of the articular 
cartilage. Walsh and co-workers utilized periosteal tissue in rabbits, showed both 
hyaline cartilage and bone growing in the repair tissue at the end of the 24- week 
trial. The results from perichondral tissue were not much better; these 12-month 
sheep tests gave repair tissue that resembled the meniscus grossly, but the tensile 
modulus of the repair tissue was much lower than native menisci. Besides that, 
collagen based scaffolds have also been developed from porcine small intes-
tine submucosa (SIS) but however they failed to portray consistent results in 
 experimental animal studies [13, 14].
Next, naturally derived ECM components include collagen, proteoglycans 
and elastin molecules. These scaffolds were made from collagen retrieved 
from bovine tendons and then molded into a circumferential orientation. It is 
now is already in phase II clinical trials. Collagen scaffolds portrayed a more 
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convincing result whereby Stone, Rodkey, and co-workers used collagen-GAG 
scaffolds [15].
Attempts in developing decellularized tissues while retaining its ECM properties 
have been recently studied. Simple tissues as well as complicated organs have been 
decellularized and decellularization methods have been optimized to completely 
remove the cellular components while keeping the ECM intact. ECM scaffolds and 
substrates are very ideal candidates for tissue engineering as it functions in provid-
ing supporting materials for cell regulations and functions such as cell survival, 
proliferation, morphogenesis and differentiation. By comparing these three types of 
scaffolds, it is undeniable to claim that decellularized based scaffolds which could 
still contain ECM properties hold the greatest potential in developing ideal scaffolds 
for meniscus. The next sub topic will be discussed trials to develop decellularized 
matrices various techniques; biological, chemical and physical methods.
4. Decellularized meniscal scaffolds
Decellularized scaffolds are expected to provide a better alternative for implant 
development in tissue engineering. Besides of it being a suitable microenvironment 
for cells, it also preserves appropriate meniscal geometry. Nevertheless, some chal-
lenges should be addressed to obtain ideal meniscal scaffolds. Because of meniscus 
natural shape, it will make it tougher for cells to evenly penetrate a decellularized 
meniscus. Not only that, an abundance of bone morphogenetic protein-2 (BMP-2), 
a member of the TGF-𝛽 superfamily will directly stimulate MSC differentiation and 
can affect cell migration [16]. A study by Minehara et al. used recombinant human 
bone morphogenetic protein-2 (rhBMP-2) loading in solvent-preserved human 
menisci to induce migration of chondrocytes into decellularized which successfully 
induces migration of chondrocytes thus improving proteoglycan production in vitro 
[17]. Thus, decellularized scaffolds face a challenge of allowing better cell penetra-
tion and migration which depends on variety kinds of exogenous chemokines.
One of the effective detergents used to decellularize menisci is SDS whereby 
collagen structure is retained [18]. Biomechanical testing using repetitive ball 
indentation test (stiffness, N/mm; residual force, N; relative compression force, 
N) on the processed tissue were similar to those of the intact meniscus, and the 
histological results showed no residual cells. Besides that, Maier et al. used a 
self-developed enzymatic process to treat ovine menisci whereby results suggested 
that native cells and immunogenic proteins (MHC-1/MHC-2) are completely 
removed while retaining significant biomechanical traits [19]. On the other side, 
Stabile et al. attempted to improve the porosity of decellularized scaffolds by 
applying concomitant decellularization and oxidation processes [20]. Azhim et al. 
implemented neoteric sonication decellularization system to produce decellular-
ized bovine meniscal scaffolds [21]. These scaffolds provide similar biomechanical 
properties of native meniscus, and were able to completely remove the immuno-
genic cell components. However, the sonication treatment compromised the native 
ECM components and collagen fiber arrangement. Thus, using decellularized 
scaffolds are great alternative for implants but more improvising needs to be done 
in order for successful integration into patients.
5. Decellularization strategies
Biological scaffolds had been widely used in tissue engineering and regenera-
tive medicine field because it virtually resembles native tissue due to the presence 
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of versatile bioactive nature within the extracellular matrix components [22]. 
The preparation of natural biological scaffolds involves a process known as decel-
lularization as shown in Figure 1. Decellularization is a process that removes whole 
cellular components within the existing tissue while preserving the composition, 
integrity and mechanics of the three dimensional extracellular matrix scaffolds 
to the extent possible [23, 24]. The elimination of the antigens and cellular com-
ponents from the tissue-derived scaffolds able to reduce the potential immune 
rejection and inflammation from occurring [25]. The choice of decellularization 
method varies depending on the characteristics of the particular tissues itself such 
as geometric considerations, cells and matrix density [26, 18]. An effective and ideal 
decellularization process supposedly manages to balance the removal of cellular 
components and preservation of matrix. There are various techniques that had 
been developed to obtain the most effective outcomes for fabrication of meniscus 
bioscaffolds using decellularization process. According to Chen & Kawazoe and 
Gilbert, to obtain an effective decellularization effect, it is encouraged for the 
method to be applied in combination [22, 26].
Three main strategies had been performed comprised of biological, chemicals 
and physical methods. For biological method, it is based on treatments using the 
enzymes such as proteases (trypsin, dispase), nucleases (DNase & RNase), col-
lagenase, lipase and others [23, 27]. Enzymes are known as substances that have 
high specificity onto biological substrate which able to cleave or hydrolyze the 
particular bonds within the tissue structure during decellularization. According 
to Badylak et al. enzymatic decellularization treatment need a long treatment 
time and has difficulty to achieve complete cellular components removal alone 
[28]. Moreover, an extensive treatment time up to 2 days will affecting the ECM 
ultrastructure components, thus weakening the mechanical properties of the 
tissues. A study done by Maier et al. treated ovine meniscus with trypsin, col-
lagenase and protease enzyme had successfully decellularized the tissue but with 
GAGs destruction [19].
The second option is the chemical methods which are further expanded into 
acid & based treatments, alcohols and also surfactants. According to Seiichi et al., 
chemical detergents treatment was investigated to be the most commonly used for 
decellularization technique [29]. The mechanism of acid& bases in decellularizing 
tissues is by catalyzing hydrolytic degradation of the biomolecules that able to dis-
sociate the DNA from the ECM and disrupting nucleic acid [23, 30]. Chen et al. had 
performed a decellularization of porcine meniscus using five types of acid consist 
of acetic acid, formic acid, peracetic acid, succinic acid, malic acid and citric acid 
with different acid immersion incubation time of 2, 4, 6, 8, 10 and 12 hours [31]. 
The results portrayed that formic acid with 2 h immersion treatment is the most 
Figure 1. 
Decellularization and recellularization of meniscus tissue.
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effective because it managed to remove almost 96% of the DNA contents with 
minor adverse effect on ECM collagens and GAGs [31].
Various types of surfactants widely available for decellularization known as 
ionic, nonionic and zwitterionic detergents. Ionic detergent is recognized as the 
strongest acting detergent compared to others which are the most broadly applied 
in decellularization process [27, 32]. Sodium dodecyl sulfate (SDS), Triton X-200 
and sodium deoxycholate are the examples of ionic detergents which are the 
commonly used for various types of tissue. In 2009, Sandmann et al. investigated 
and published a study on the effect of 2% SDS with 2 weeks incubation time onto 
biomechanical strength of human meniscus tissues [33]. It was proven that 2% SDS 
achieved complete cells removal with minor negative impacts on the biomechanical 
properties of prepared decellularized human meniscus.
Biological and chemical treatments might result in residual toxicity within the 
tissues, thus physical treatment for decellularization had been developed. Physical 
treatments involve freeze–thaw, high hydrostatic pressure, agitation and sonication 
to disrupt cell membranes and release the cellular components. High hydrostatic 
pressure system decellularized the tissue by applying pressure from specialized 
equipment that lead to high cost requirement. This system able to decellularize the 
tissue in short treatment time but have high risk of extracellular matrix (ECM) 
ultrastructure disruption due to baric formation of ice crystals throughout the 
process [34].
In 2010, a novel sonication decellularization with open system had been 
developed as a new candidate categorized under physical treatment. Sonication 
system utilizes the ultrasound power assisted by sodium dodecyl sulfate (SDS) to 
maximize the decellularization efficiency. Researchers and expertise have used 
ultrasound technology in a wide range of activities such as electrochemistry, food 
technology, chemical synthesis, material extraction, nanotechnology and surface 
cleaning [35]. Recently, the application of ultrasound is said to be one of the 
popular method for cell disruption, emulsification and homogenizing of biological 
matter [36]. The potential of ultrasound has lead to the development of sonication 
treatment.
Since 2010, a pilot study had been started by using aorta [21, 38–42] and 
meniscus tissues [21, 37, 43, 44] as model by testing using different sonication 
frequency and different percentage of SDS solution concentration that suit with 
the characteristics of the tissue [21, 37–41]. As for decellularized meniscus tis-
sue preparation, primary study was done using 20 kHz frequency with 2% SDS 
solution for 10 hours treatment time that resulted in highest cells removal but 
there was minor presence of cells observed [37]. Thus, further study was done by 
increasing the sonication to 40 kHz frequency while minimizing the SDS concen-
tration to 0.1% in order to preserve the bioscaffolds properties [21]. This study 
compared the sonication treated tissue with immersion treatment as control and 
native tissue. Based on the result of van Gieson staining portrayed in Figure 2, it 
revealed the complete cells removal from meniscus tissue by sonication system 
(C) where there is no nuclei stained can be observed compared to control (B) and 
native (A).
In 2014, Azhim et al. had developed a novel closed sonication decellularization 
system as shown in Figure 3. The ultrasonic transducer is the source of sonication 
that has three different set of frequency of 40, 120 and 170 kHz. The decellulariza-
tion efficiency of sonication system was contributed mainly by sonication and also 
SDS detergent. Firstly, sonication influences the process by the disruption of the cell 
membrane and cell contents release by its phenomenon of acoustic cavitation. Besides 
that, sonication also assists the flow of SDS solution that thoroughly penetrates 
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within tissue sample. Ionic SDS detergents aid in decellularization by solubilizing 
nuclear cellular membranes and removing cells residues from the tissue specimens.
6. Recellularization strategies for regeneration of engineered meniscus
In tissue engineering and regenerative medicine, the preparation of engineered 
meniscus tissue required triad components comprised of scaffolds, cells and 
growth factors. Basically, the cells will be recellularized onto artificial or natural 
biological scaffolds with the presence of growth factors for regeneration of tissue. 
Recellularization using the three dimensional decellularized scaffolds had been 
one of the attention recently because it resembles natural tissue that have similar 
biological compositions of the ECM. It is therefore an advantage for the decellular-
ized scaffolds to provide a better environment for the adhesion, differentiation and 
proliferation of the seeded cells to regenerate functional tissues [45, 46].
According to Chen, recellularization is a crucial part in tissue engineering where 
cell-seeded constructs can be prepared [31]. This constructs are believed to have 
many potential advantages for in vitro and in vivo study. First and foremost, it 
Figure 2. 
Photographs of van Gieson staining from surface part of native tissue (A), immersion treated tissue (B), 
sonication treated tissue (C) with 40× magnification. Yellow circle demonstrated the dark blue nuclei stained [21].
Figure 3. 
Sonication decellularization system consists of ultrasonic transducers, pump, cooling water bath, reactor, 
actuator, temperature monitor, hydrophone, and multiparameter meter that consists of dissolved oxygen (DO), 
conductivity and pH sensor [39].
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manages to provide specific microenvironment for cells to proliferate and perform 
cellular activities for production of ECM. Besides that, cell seeded constructs also 
ease the integration between scaffolds and native tissues once implanted into the 
recipient [31].
The advancements of tissue engineering nowadays had the potential to drive 
meniscus regeneration into clinically relevant strategies and as a promising avenue 
to improve meniscus repair. For meniscus tissue engineering, various types of cell 
sources currently being utilized for recellularization process to prepare the cell 
seeded constructs [47–49]. Different types of cells stimulate different outcome. 
Ideal cells that suitable for recellularization of meniscus scaffolds should be easy 
to obtain, low immunogenicity level and able to regenerate the ECM components 
within the tissue [7]. In this chapter, we will give an overview of promising cell 
sources that hold great potential meniscus tissue regeneration. There are two main 
classifications of promising cells available for seeding processes which are stem 
cells/progenitor cells and mature cells. Table 1 summarizes the cell sources that are 
available and broadly applied in meniscus tissue engineering.
6.1 Stem cells/progenitor cells
Stem cells are known as undifferentiated cells that able to proliferate and differ-
entiate into many specialized cell types. Two main characteristics of stem cells that 
distinguish them with other cells is that stem cells are multipotent where it can be 
induced into specific tissue with specific functions and it has long term self-renewal 
[50, 51]. Mesenchymal stem cells are the most studied stem cells that can be harvested 
from several musculoskeletal tissues such as bone, bone marrow, adipose tissue, 
synovial membrane and cartilage [47, 52]. Drawbacks of using mesenchymal stem 
cells lies in the complex understanding of required stimuli to direct the differentiation 
process to a desired lineage [48]. Besides that, once the microenvironment changes 
and undergo hypertrophy, the differentiated phenotype can be easily lost [53].
Bone marrow mesenchymal stem cells (BM-MSCs) derived from bone marrow 
compartment with high proliferative activity is identified as heterogeneous popula-
tion of stem cells capable to undergo self-renewal [54]. The extraction of BM-MSCs 
is quit complex because need to undergo bone marrow aspiration procedure 
which is invasive. BM-MSCs have the ability to differentiate into three lineages of 
skeletal tissue cells in appropriate in vitro condition; osteoblasts, adipocytes and 
chondrocytes [55]. Few studies had been attempted in meniscus tissue engineering 
using BM-MSCs. An in vitro study performed by Yamasaki et al., 2 × 105 cells were 
seeded onto decellularized rat meniscus in 48 well plate, incubated for 1, 2 and 
4 weeks the cell-scaffolds constructs were evaluated with few analyses [56]. The 
results obtained from the analyses revealed that there was sufficient repopulation 
of BM-MSCs within the scaffolds. It was noted that there was sufficient genera-
tion of ECM compositions such as collagen and GAGs over 4 weeks in culture that 
resembles the content in control group. Evaluation of mechanical integrity for 
regenerated tissues portrayed similar stiffness with normal meniscus tissue after 
incubated 2 weeks in vitro culture. Unfortunately, this study lack of in vivo study 
which will be done in further study.
Adipose stem cells (ASCs) are considered as alternative cell sources that avail-
able in emerging tissue regeneration. This ASCs was discovered in the early 2000 
that have high self-renewal capacity and capable to differentiate into three differ-
ent cell lineages known as adipocytes, osteoblast and chondrocytes if subjected to 
desired stimuli [47]. It was reported that the isolation of ASCs is easier compared 
to BM-MSc that are commonly isolated from the intrapatellar fat pad of the knee 
and is not invasive. [57, 58]. An in vitro study using adipose mesenchymal stem 
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cells seeded on four types of different scaffolds incubated for 3 days had been 
accomplished by Moradi et al. in 2017 [59]. The cell seeded scaffolds were evaluated 
for mechanical integrity, biocompatibility and gene expression. The performed 
real time PCR after 3 weeks culture concluded that ASCs scaffolds had an increase 
in aggrecan and collagen type II expression compared to control group. For in vivo 
study, the ASCs scaffolds were implanted into rabbit model for 7 months to discover 
neomeniscus tissue formation. It was resulted that ASCs scaffolds were found to 
generate homogenous neomeniscus with poor quality [59].
In 2001, a study conducted by De Bari et al. that characterized the synovial 
MSCs reported that the cells capable to proliferate extensively and maintained their 
multilineage differentiation potential in vitro culture [60]. According to Ozeki 
et al., his study chose synovium MSCs to be seeded onto tendon grafts and assessed 
Classification of 
cells
Type of cells Results References
Stem cells/
progenitor cells
Bone-marrow (BM)-
derived MSCs
Extracellular matrices was 
successfully synthesized at early 
phase with adequate stiffness 
observed after 2 weeks culture.
[56]
Synovium MSCs Early phase of synovial coverage 
on injured area was induced and 
promoted meniscus regeneration
[61]
Adipose stem cells 
(ASCs)
Managed to partially formed 
meniscus-like tissue with no 
detectable amount of GAG
[59]
Cartilage progenitor 
cells (CPCs)
Cells migrated to the tears injury site 
while promoting bridging across 
the site
[64]
Myoblast High cell yield, rapid proliferation 
activity with similar biochemical 
compositions compared to control
[66]
Articular chondrocytes Cells proliferated and synthesized 
ECM production (collagen & gag)
[68]
High proliferation rates and the 
tissue generated had notable amount 
of GAG and collagen type II
[66]
Cells infiltrated rapidly and 
distributed evenly in vitro and 
in vivo at Day 14
[69]
Chondrocytes able to synthesized 
meniscal tissue in an in vivo situation
[69]
Mature cells Fibrochondrocytes Cells survived and proliferated for 
over 28 days, demonstrating the 
feasibility of culturing cells within 
ECM scaffolds
[70]
The cells manages to self assemble 
and produced ECM matrix of 
collagen type I and proteoglycans
[71]
Fibroblasts Fibroblastic cell morphology 
attached and infiltrated into the 
surface of scaffolds
[75]
Table 1. 
Cells sources for meniscus tissues regeneration.
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the meniscus regeneration through in vitro and in vivo. It was revealed that the ten-
don grafts with synovial MSCs succeeded to induce early phase of synovial coverage 
at the defect site and had better integration with the meniscus defect that promote 
meniscus regeneration compared to control group [61].
Recently, cartilage progenitor cells (CPCs) represented as new and potential 
great cell sources available for cartilage and meniscus tissue regeneration. CPCs are 
basically obtained from the full thickness of mature cartilage. The chondrocytes 
population was first isolated and need to further undergo differential adhesion to 
fibronectin process in order to obtain the CPCs [47, 62]. It was identified that CPCs 
appeared in fibrochondrocytes-like appearance with chondrogenic potential. These 
CPCs were reviewed to be resistant towards common problems faced by MSCs 
recognized as terminal differentiation and also hypertrophy [47, 63]. Hypertrophy 
is a situation where the cells tend to enlarge with increase in cell mass that required 
more energy [63]. According to Williams, CPSs were reported to experience better 
complex chondrogenesis processes compared to other mesenchymal stem cells 
[62]. CPCs supplied onto meniscus with tears demonstrated that the cells capable 
to migrate to the tears site of tears injury while promoting bridging across the site 
[64]. Unfortunately, the study about CPCS in meniscus tissue engineering is still 
limited.
Myoblasts are considered as adult stem cells candidate that have multiple differ-
entiation potentials that capable to differentiate mainly into myocytes, adipocytes 
and osteocytes [65]. Myoblasts were recognized as easily accessed cells with rela-
tively abundant availability with acute donor site morbidity [66, 67]. Chondrogenic 
differentiation of myoblasts within PLGA scaffolds was concluded to have high cell 
yields with rapid cells proliferation. Besides that, it was observed that the biochemi-
cal compositions and mechanical strength of the implanted myoblast-scaffolds was 
similar to native tissue [66].
6.2 Mature cells
Mature cells are a nonprogenitor cells including chondrocytes, fibrochondro-
cytes and fibroblasts able to be derived from cartilage, meniscus and dermal tissues. 
The application of mature cells somehow managed to overcome major limitation of 
stem cells that mainly facing the hypertrophy occurrence [47].
As for articular chondrocytes (AC), it is principally derived from articular 
cartilage and can enzymatically isolate. A recent study was done where chondro-
cytes were seeded directly onto the layer of decellularized porcine meniscus and 
incubated for up to 28 days. It was reported that the cells able to proliferate healthily 
and synthesized the extracellular matrix such as collagen type II and GAG within 
the scaffolds [68]. Besides that, according to an analysis done by Marsano et al. that 
seeded the cells onto 3D pellet culture to investigate the growth and post-expansion 
chondrogenic capacity of chondrocytes [67]. Based on the evaluation done after 
pellet culture for 2, 4 and 6 weeks, it was indicated that articular chondrocytes 
resulted in high proliferation rate. This AC generated tissue was found to form 
abundant GAG and collagen type II in inner avascular region at the same time 
produced collagen type IV in outer vascular region [67]. There had been two other 
studies portrayed in Table 1 that recellularized scaffolds with chondrocytes for 
meniscus regeneration [69, 70].
Meniscal fibrochondrocytes are investigated as one of the cell sources for 
meniscus regeneration which can be extracted easily from meniscus [19, 71]. 
Fibrochondrocytes distributed in all regions of meniscus but dominates more 
in the vascular outer layer that mainly composed of Type I collagen. The mul-
tilineage differentiation particularly favors more towards chondrogenesis and 
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adipogenesis [72]. A study done by Maier et al. 2007 had successfully seeded the 
fibrochondrocytes onto the decellularized ovine meniscus. The results showed 
that the cells managed to infiltrate, survive and proliferate for more than 28 days 
in the scaffolds [19].
The red-red region of the meniscus that mainly exhibit collagen type II consist 
of fibroblast-like cells with elongated morphology [73]. This kind of cells frequently 
derived from reliable sources such as dermal skin that obtained from different body 
sites and also meniscus tissues. Fibroblasts play important roles in physiological 
process essentially in ECM production, inflammation and wound healing regulation 
[74]. Stapleton et al. had constructed decellularized scaffolds using freeze thaw 
method and Sodium dodecyl sulfate (SDS) detergent [75]. The prepared scaffolds 
were utilized for recellularization process using dermal fibroblasts cells for 7 days 
and proceed with implantation in GTKO mice. Based on the evaluation after 7 days 
of culture in decellularized meniscus, the fibroblasts successfully infiltrate the scaf-
folds to a depth of 150 mm and the cells were found to appear on the surface with 
flattened morphology [75].
7. Future prospects for meniscal tissue engineering
There is a dearth in the number of studies done currently in engineering menis-
cus as compared to other tissues like articular cartilage. The fundamental knowl-
edge on meniscus and its mechanism needs to be fully understood for researchers 
and clinicians to target a problem. Besides that, knowledge fibrochondrocytes, 
chondrocytes and other mesenchymal stem cells reactions to a variety of growth 
factors need to be understood through a variety of tests, both from tissue engineer-
ing studies and meniscal repair enhancement studies. Meniscus scaffolds for future 
application should focus on engineering the entire functional unit which includes 
meniscal body with anterior and posterior ligaments. Great perception regarding 
the characteristics of the meniscus constructs in designing for meniscal replacement 
is important to the overall function. However, an intensive attempt in discovering 
the appropriate seed cells, biological and mechanical strength stimulation should be 
given more attention. Broad study on cell sources chose for recellularization should 
focusing more to in vivo study in animal model. The well performance of in vivo 
study might depend on several factors such as the quality of neotissue formed dur-
ing in vitro. More importantly, the fabrication of engineered meniscus tissue with 
excellent mechanical strength and function that mimic native tissue is the key issue 
in this field. Good mechanical strength contributes to normal meniscus function. 
Besides that, three-dimensional construct printing could profit the development of 
meniscal scaffolds ideally. In short, the development bio-engineering ideal scaffolds 
for meniscal tissue engineering applications depend on the ability to preserve the 
biomechanical and biochemical properties of the tissue. The scaffolds should be 
biocompatible and emit minimum inflammatory effect on to the host.
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